Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis

Benson, Merrill DAckermann, Elizabeth JMonia, Brett P2016-10-202016-10-202015-11-02Benson, M. D., Ackermann, E. J., & Monia, B. P. (2015). Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis. Orphanet Journal of Rare Diseases, 10(Suppl 1), P7. http://doi.org/10.1186/1750-1172-10-S1-P71750-1172https://hdl.handle.net/1805/11214en-USAttribution 3.0 United StatesTransthyretin AmyloidosisOligonucleotides, AntisenseCardiomyopathiesNeuropathiesTreatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesisArticle